Selected research
Industry Growth & Trends
Global CD11b Antibody Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global CD11b Antibody market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for CD11b Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for CD11b Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for CD11b Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the CD11b Antibody market include Merck, Boster Biological Technology, United States Biological, Synaptic, Santa Cruz Biotechnology, Proteintech, Miltenyi Biotec, Hytest and GeneTex, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global CD11b Antibody market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The CD11b Antibody market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global CD11b Antibody market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to CD11b Antibody.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global CD11b Antibody market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
CD11b Antibody Market by Company
Merck
Boster Biological Technology
United States Biological
Synaptic
Santa Cruz Biotechnology
Proteintech
Miltenyi Biotec
Hytest
GeneTex
FineTest
EXBIO
Everest Biotech
Bio-Rad
BioLegend
Bio X Cell
Beckman Coulter
Atlas Antibodies
CD11b Antibody Segment by Type
Polyclonal
Monoclonal
CD11b Antibody Segment by Application
Western Blot
Flow Cytometry
Enzyme Linked Immunosorbent Assay
Immunoprecipitation
Immunofluorescence
Others
CD11b Antibody Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global CD11b Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of CD11b Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of CD11b Antibody.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of CD11b Antibody companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Polyclonal
- Monoclonal
Applications
- Western Blot
- Flow Cytometry
- Enzyme Linked Immunosorbent Assay
- Immunoprecipitation
- Immunofluorescence
- Others
Companies covered
- Merck
- Boster Biological Technology
- United States Biological
- Synaptic
- Santa Cruz Biotechnology
- Proteintech
- Miltenyi Biotec
- Hytest
- GeneTex
- FineTest
- EXBIO
- Everest Biotech
- Bio-Rad
- BioLegend
- Bio X Cell
- Beckman Coulter
- Atlas Antibodies
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global CD11b Antibody Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global CD11b Antibody Market Size by Region (2021-2032)
- 1.4.1 Global CD11b Antibody Market Size by Region (2021-2026)
- 1.4.2 Global CD11b Antibody Market Size by Region (2027-2032)
- 1.5 Key Regions CD11b Antibody Market Size (2021-2032)
- 1.5.1 North America CD11b Antibody Market Size Growth Rate (2021-2032)
- 1.5.2 Europe CD11b Antibody Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific CD11b Antibody Market Size Growth Rate (2021-2032)
- 1.5.4 South America CD11b Antibody Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa CD11b Antibody Market Size Growth Rate (2021-2032)
2 CD11b Antibody Market by Type
- 2.1 Type Introduction
- 2.1.1 Polyclonal
- 2.1.2 Monoclonal
- 2.2 Global CD11b Antibody Market Size by Type
- 2.2.1 Global CD11b Antibody Market Size Overview by Type (2021-2032)
- 2.2.2 Global CD11b Antibody Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global CD11b Antibody Market Size Forecasted by Type (2027-2032)
- 2.3 Global CD11b Antibody Market Size by Regions
- 2.3.1 North America CD11b Antibody Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe CD11b Antibody Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific CD11b Antibody Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America CD11b Antibody Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa CD11b Antibody Market Size Breakdown by Type (2021-2026)
3 CD11b Antibody Market by Application
- 3.1 Type Introduction
- 3.1.1 Western Blot
- 3.1.2 Flow Cytometry
- 3.1.3 Enzyme Linked Immunosorbent Assay
- 3.1.4 Immunoprecipitation
- 3.1.5 Immunofluorescence
- 3.1.6 Others
- 3.2 Global CD11b Antibody Market Size by Application
- 3.2.1 Global CD11b Antibody Market Size Overview by Application (2021-2032)
- 3.2.2 Global CD11b Antibody Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global CD11b Antibody Market Size Forecasted by Application (2027-2032)
- 3.3 Global CD11b Antibody Market Size by Regions
- 3.3.1 North America CD11b Antibody Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe CD11b Antibody Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific CD11b Antibody Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America CD11b Antibody Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa CD11b Antibody Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 CD11b Antibody Industry Trends
- 4.2 CD11b Antibody Industry Drivers
- 4.3 CD11b Antibody Industry Opportunities and Challenges
- 4.4 CD11b Antibody Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by CD11b Antibody Revenue (2021-2026)
- 5.2 Global CD11b Antibody Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global CD11b Antibody Key Company Headquarters & Area Served
- 5.4 Global CD11b Antibody Company, Product Type & Application
- 5.5 Global CD11b Antibody Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global CD11b Antibody Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 CD11b Antibody Players Market Share by Revenue in 2025
- 5.6.3 2025 CD11b Antibody Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Merck
- 6.1.1 Merck Company Information
- 6.1.2 Merck Business Overview
- 6.1.3 Merck CD11b Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Merck CD11b Antibody Product Portfolio
- 6.1.5 Merck Recent Developments
- 6.2 Boster Biological Technology
- 6.2.1 Boster Biological Technology Company Information
- 6.2.2 Boster Biological Technology Business Overview
- 6.2.3 Boster Biological Technology CD11b Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Boster Biological Technology CD11b Antibody Product Portfolio
- 6.2.5 Boster Biological Technology Recent Developments
- 6.3 United States Biological
- 6.3.1 United States Biological Company Information
- 6.3.2 United States Biological Business Overview
- 6.3.3 United States Biological CD11b Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 United States Biological CD11b Antibody Product Portfolio
- 6.3.5 United States Biological Recent Developments
- 6.4 Synaptic
- 6.4.1 Synaptic Company Information
- 6.4.2 Synaptic Business Overview
- 6.4.3 Synaptic CD11b Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Synaptic CD11b Antibody Product Portfolio
- 6.4.5 Synaptic Recent Developments
- 6.5 Santa Cruz Biotechnology
- 6.5.1 Santa Cruz Biotechnology Company Information
- 6.5.2 Santa Cruz Biotechnology Business Overview
- 6.5.3 Santa Cruz Biotechnology CD11b Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Santa Cruz Biotechnology CD11b Antibody Product Portfolio
- 6.5.5 Santa Cruz Biotechnology Recent Developments
- 6.6 Proteintech
- 6.6.1 Proteintech Company Information
- 6.6.2 Proteintech Business Overview
- 6.6.3 Proteintech CD11b Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Proteintech CD11b Antibody Product Portfolio
- 6.6.5 Proteintech Recent Developments
- 6.7 Miltenyi Biotec
- 6.7.1 Miltenyi Biotec Company Information
- 6.7.2 Miltenyi Biotec Business Overview
- 6.7.3 Miltenyi Biotec CD11b Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Miltenyi Biotec CD11b Antibody Product Portfolio
- 6.7.5 Miltenyi Biotec Recent Developments
- 6.8 Hytest
- 6.8.1 Hytest Company Information
- 6.8.2 Hytest Business Overview
- 6.8.3 Hytest CD11b Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Hytest CD11b Antibody Product Portfolio
- 6.8.5 Hytest Recent Developments
- 6.9 GeneTex
- 6.9.1 GeneTex Company Information
- 6.9.2 GeneTex Business Overview
- 6.9.3 GeneTex CD11b Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 GeneTex CD11b Antibody Product Portfolio
- 6.9.5 GeneTex Recent Developments
- 6.10 FineTest
- 6.10.1 FineTest Company Information
- 6.10.2 FineTest Business Overview
- 6.10.3 FineTest CD11b Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 FineTest CD11b Antibody Product Portfolio
- 6.10.5 FineTest Recent Developments
- 6.11 EXBIO
- 6.11.1 EXBIO Company Information
- 6.11.2 EXBIO Business Overview
- 6.11.3 EXBIO CD11b Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 EXBIO CD11b Antibody Product Portfolio
- 6.11.5 EXBIO Recent Developments
- 6.12 Everest Biotech
- 6.12.1 Everest Biotech Company Information
- 6.12.2 Everest Biotech Business Overview
- 6.12.3 Everest Biotech CD11b Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Everest Biotech CD11b Antibody Product Portfolio
- 6.12.5 Everest Biotech Recent Developments
- 6.13 Bio-Rad
- 6.13.1 Bio-Rad Company Information
- 6.13.2 Bio-Rad Business Overview
- 6.13.3 Bio-Rad CD11b Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Bio-Rad CD11b Antibody Product Portfolio
- 6.13.5 Bio-Rad Recent Developments
- 6.14 BioLegend
- 6.14.1 BioLegend Company Information
- 6.14.2 BioLegend Business Overview
- 6.14.3 BioLegend CD11b Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 BioLegend CD11b Antibody Product Portfolio
- 6.14.5 BioLegend Recent Developments
- 6.15 Bio X Cell
- 6.15.1 Bio X Cell Company Information
- 6.15.2 Bio X Cell Business Overview
- 6.15.3 Bio X Cell CD11b Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Bio X Cell CD11b Antibody Product Portfolio
- 6.15.5 Bio X Cell Recent Developments
- 6.16 Beckman Coulter
- 6.16.1 Beckman Coulter Company Information
- 6.16.2 Beckman Coulter Business Overview
- 6.16.3 Beckman Coulter CD11b Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Beckman Coulter CD11b Antibody Product Portfolio
- 6.16.5 Beckman Coulter Recent Developments
- 6.17 Atlas Antibodies
- 6.17.1 Atlas Antibodies Company Information
- 6.17.2 Atlas Antibodies Business Overview
- 6.17.3 Atlas Antibodies CD11b Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Atlas Antibodies CD11b Antibody Product Portfolio
- 6.17.5 Atlas Antibodies Recent Developments
7 North America
- 7.1 North America CD11b Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America CD11b Antibody Market Size by Country (2021-2026)
- 7.3 North America CD11b Antibody Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe CD11b Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe CD11b Antibody Market Size by Country (2021-2026)
- 8.3 Europe CD11b Antibody Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific CD11b Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific CD11b Antibody Market Size by Country (2021-2026)
- 9.3 Asia-Pacific CD11b Antibody Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America CD11b Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America CD11b Antibody Market Size by Country (2021-2026)
- 10.3 South America CD11b Antibody Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa CD11b Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa CD11b Antibody Market Size by Country (2021-2026)
- 11.3 Middle East & Africa CD11b Antibody Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst